{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Greenville",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78544",
      "recalling_firm": "Mayne Pharma Inc",
      "address_1": "1240 Sugg Pkwy",
      "address_2": "N/A",
      "postal_code": "27834-9006",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within USA",
      "recall_number": "D-0098-2018",
      "product_description": "Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles,  Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01",
      "product_quantity": "11,364 bottles",
      "reason_for_recall": "Failed Dissolution Specifications.",
      "recall_initiation_date": "20171109",
      "center_classification_date": "20171129",
      "termination_date": "20200511",
      "report_date": "20171206",
      "code_info": "Lot: #:16F649, Exp: May 2018"
    }
  ]
}